177 related articles for article (PubMed ID: 38600056)
1. Network-based identification of key proteins and repositioning of drugs for non-small cell lung cancer.
Adeyemo OM; Ashimiyu-Abdusalam Z; Adewunmi M; Ayano TA; Sohaib M; Abdel-Salam R
Cancer Rep (Hoboken); 2024 Apr; 7(4):e2031. PubMed ID: 38600056
[TBL] [Abstract][Full Text] [Related]
2. Drug repositioning in non-small cell lung cancer (NSCLC) using gene co-expression and drug-gene interaction networks analysis.
MotieGhader H; Tabrizi-Nezhadi P; Deldar Abad Paskeh M; Baradaran B; Mokhtarzadeh A; Hashemi M; Lanjanian H; Jazayeri SM; Maleki M; Khodadadi E; Nematzadeh S; Kiani F; Maghsoudloo M; Masoudi-Nejad A
Sci Rep; 2022 Jun; 12(1):9417. PubMed ID: 35676421
[TBL] [Abstract][Full Text] [Related]
3. Identification of key microRNAs and hub genes in non-small-cell lung cancer using integrative bioinformatics and functional analyses.
Song F; Xuan Z; Yang X; Ye X; Pan Z; Fang Q
J Cell Biochem; 2020 Mar; 121(3):2690-2703. PubMed ID: 31692035
[TBL] [Abstract][Full Text] [Related]
4. RNA-Seq analysis of non-small cell lung cancer in female never-smokers reveals candidate cancer-associated long non-coding RNAs.
Li J; Bi L; Shi Z; Sun Y; Lin Y; Shao H; Zhu Z
Pathol Res Pract; 2016 Jun; 212(6):549-54. PubMed ID: 27067812
[TBL] [Abstract][Full Text] [Related]
5. Drug repositioning for non-small cell lung cancer by using machine learning algorithms and topological graph theory.
Huang CH; Chang PM; Hsu CW; Huang CY; Ng KL
BMC Bioinformatics; 2016 Jan; 17 Suppl 1(Suppl 1):2. PubMed ID: 26817825
[TBL] [Abstract][Full Text] [Related]
6. MYLK and MYL9 expression in non-small cell lung cancer identified by bioinformatics analysis of public expression data.
Tan X; Chen M
Tumour Biol; 2014 Dec; 35(12):12189-200. PubMed ID: 25179839
[TBL] [Abstract][Full Text] [Related]
7. Systems biology strategy and experimental validation to uncover the pharmacological mechanism of Xihuang Pill in treating non-small cell lung cancer.
Zhuang Z; Huang D; Sheng ZR; Ye ZJ; Jiang H; Yuan Y; Qin B; Zhao Y; Pan HF; Tang Y
Phytomedicine; 2023 Jan; 108():154491. PubMed ID: 36368285
[TBL] [Abstract][Full Text] [Related]
8. Using biological information to analyze potential miRNA-mRNA regulatory networks in the plasma of patients with non-small cell lung cancer.
Zhang W; Zhang Q; Che L; Xie Z; Cai X; Gong L; Li Z; Liu D; Liu S
BMC Cancer; 2022 Mar; 22(1):299. PubMed ID: 35313857
[TBL] [Abstract][Full Text] [Related]
9. Identification and validation of key genes with prognostic value in non-small-cell lung cancer via integrated bioinformatics analysis.
Wang L; Qu J; Liang Y; Zhao D; Rehman FU; Qin K; Zhang X
Thorac Cancer; 2020 Apr; 11(4):851-866. PubMed ID: 32059076
[TBL] [Abstract][Full Text] [Related]
10. Considering smoking status, coexpression network analysis of non-small cell lung cancer at different cancer stages, exhibits important genes and pathways.
Mortezaei Z; Tavallaei M; Hosseini SM
J Cell Biochem; 2019 Nov; 120(11):19172-19185. PubMed ID: 31271232
[TBL] [Abstract][Full Text] [Related]
11. Systematic bioinformatic approaches reveal novel gene expression signatures associated with acquired resistance to EGFR targeted therapy in lung cancer.
Mojtabavi Naeini M; Tavassoli M; Ghaedi K
Gene; 2018 Aug; 667():62-69. PubMed ID: 29758295
[TBL] [Abstract][Full Text] [Related]
12. Identification of target gene and prognostic evaluation for lung adenocarcinoma using gene expression meta-analysis, network analysis and neural network algorithms.
Selvaraj G; Kaliamurthi S; Kaushik AC; Khan A; Wei YK; Cho WC; Gu K; Wei DQ
J Biomed Inform; 2018 Oct; 86():120-134. PubMed ID: 30195659
[TBL] [Abstract][Full Text] [Related]
13. Identification and Integrated Analysis of Key Biomarkers for Diagnosis and Prognosis of Non-Small Cell Lung Cancer.
Liu X; Liu X; Li J; Ren F
Med Sci Monit; 2019 Dec; 25():9280-9289. PubMed ID: 31805030
[TBL] [Abstract][Full Text] [Related]
14. High-Throughput Screen of Natural Compounds and Biomarkers for NSCLC Treatment by Differential Expression and Weighted Gene Coexpression Network Analysis (WGCNA).
Kui L; Li M; Yang X; Yang L; Kong Q; Pan Y; Xu Z; Wang S; Mo D; Dong Y; Liu Y; Miao J
Biomed Res Int; 2021; 2021():5955343. PubMed ID: 34485520
[TBL] [Abstract][Full Text] [Related]
15. Identification and validation of key genes associated with non-small-cell lung cancer.
Ma Q; Xu Y; Liao H; Cai Y; Xu L; Xiao D; Liu C; Pu W; Zhong X; Guo X
J Cell Physiol; 2019 Dec; 234(12):22742-22752. PubMed ID: 31127628
[TBL] [Abstract][Full Text] [Related]
16. Identification and Integrate Analysis of Key Biomarkers for Diagnosis and Prognosis of Non-Small Cell Lung Cancer Based on Bioinformatics Analysis.
Gong K; Zhou H; Liu H; Xie T; Luo Y; Guo H; Chen J; Tan Z; Yang Y; Xie L
Technol Cancer Res Treat; 2021; 20():15330338211060202. PubMed ID: 34825846
[No Abstract] [Full Text] [Related]
17. Metabolic gene NR4A1 as a potential therapeutic target for non-smoking female non-small cell lung cancer patients.
Sun R; Bao MY; Long X; Yuan Y; Wu MM; Li X; Bao JK
Thorac Cancer; 2019 Apr; 10(4):715-727. PubMed ID: 30806032
[TBL] [Abstract][Full Text] [Related]
18. Identification of Gene Biomarkers for Distinguishing Small-Cell Lung Cancer from Non-Small-Cell Lung Cancer Using a Network-Based Approach.
Long F; Su JH; Liang B; Su LL; Jiang SJ
Biomed Res Int; 2015; 2015():685303. PubMed ID: 26290870
[TBL] [Abstract][Full Text] [Related]
19. Bioinformatics analysis and experimental validation of TTK as a biomarker for prognosis in non-small cell lung cancer.
Chen J; Wu R; Xuan Y; Jiang M; Zeng Y
Biosci Rep; 2020 Oct; 40(10):. PubMed ID: 32969465
[TBL] [Abstract][Full Text] [Related]
20. Microarray data analysis on gene and miRNA expression to identify biomarkers in non-small cell lung cancer.
Jin X; Guan Y; Zhang Z; Wang H
BMC Cancer; 2020 Apr; 20(1):329. PubMed ID: 32299382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
